These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21626875)

  • 1. [Clinical validity of renal function markers including serum cystatin C on chronic kidney disease classification].
    Suzuki Y; Matsushita K; Yoshida T; Sawabe Y; Nomura F
    Rinsho Byori; 2011 Apr; 59(4):345-51. PubMed ID: 21626875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Usefulness of serum cystatin C for the diagnosis of impaired renal function].
    Oyabu C; Hayashi N; Sugiyama D; Umezu M; Mukai M; Kawano S; Kumagai S
    Rinsho Byori; 2006 Dec; 54(12):1204-8. PubMed ID: 17265892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystatin C and beta2-microglobulin: markers of glomerular filtration in critically ill children.
    Herrero-Morín JD; Málaga S; Fernández N; Rey C; Diéguez MA; Solís G; Concha A; Medina A
    Crit Care; 2007; 11(3):R59. PubMed ID: 17519026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison between serum cystatin C and estimation of GFR by the MDRD study equation for chronic kidney disease].
    Sakaguchi S; Tanaka A; Kawanishi T; Tanaka A; Koshikawa M; Kuwahara T
    Nihon Jinzo Gakkai Shi; 2008; 50(8):1011-6. PubMed ID: 19172802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prospective evaluation of renal function by serum cystatin-C: comparison with three other parameters of glomerular filtration rate].
    Tamba K; Kusano E; Ando Y; Asano Y
    Nihon Jinzo Gakkai Shi; 2001 Nov; 43(8):646-50. PubMed ID: 11808075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.
    Oddoze C; Morange S; Portugal H; Berland Y; Dussol B
    Am J Kidney Dis; 2001 Aug; 38(2):310-6. PubMed ID: 11479157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of serum cystatin-C as a marker of the renal function: a comparative evaluation with beta 2-microglobulin, alpha 1-microglobulin and creatinine].
    Hotta O; Yusa N; Mukaiyama I; Taguma Y
    Nihon Jinzo Gakkai Shi; 1999 Dec; 41(8):797-803. PubMed ID: 10655728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of the formula for predicting creatinine clearance from serum cystatin C].
    Oyabu C; Hayashi N; Sugiyama D; Umezu M; Kinoshita S; Hayashi H; Kawano S; Kumagai S
    Rinsho Byori; 2008 Dec; 56(12):1093-9. PubMed ID: 19175073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis.
    Sato H; Kuroda T; Tanabe N; Ajiro J; Wada Y; Murakami S; Sakatsume M; Nakano M; Gejyo F
    Scand J Rheumatol; 2010; 39(1):33-7. PubMed ID: 20132068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function.
    Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
    Nephrol Dial Transplant; 2006 Jul; 21(7):1855-62. PubMed ID: 16524933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can cystatin C be a better marker for the early detection of renal damage in primary hypertensive patients?
    Ozer BA; Dursun B; Baykal A; Gultekin M; Suleymanlar G
    Ren Fail; 2005; 27(3):247-53. PubMed ID: 15957539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of glomerular filtration rate by serum cystatin C in patients undergoing coronary artery bypass grafting.
    Wang QP; Gu JW; Zhan XH; Li H; Luo XH
    Ann Clin Biochem; 2009 Nov; 46(Pt 6):495-500. PubMed ID: 19729502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients.
    Villa P; Jiménez M; Soriano MC; Manzanares J; Casasnovas P
    Crit Care; 2005 Apr; 9(2):R139-43. PubMed ID: 15774046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease.
    Malyszko J; Bachorzewska-Gajewska H; Sitniewska E; Malyszko JS; Poniatowski B; Dobrzycki S
    Ren Fail; 2008; 30(6):625-8. PubMed ID: 18661413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cystatin C as an endogenous marker of renal function in patients with chronic kidney disease.
    Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
    Ren Fail; 2008; 30(2):181-6. PubMed ID: 18300118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of renal function in kidney donors using serum cystatin C and beta(2)-microglobulin.
    John GT; Fleming JJ; Talaulikar GS; Selvakumar R; Thomas PP; Jacob CK
    Ann Clin Biochem; 2003 Nov; 40(Pt 6):656-8. PubMed ID: 14629804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive power of serum cystatin C to detect acute kidney injury and pediatric-modified RIFLE class in children undergoing cardiac surgery.
    Hassinger AB; Backer CL; Lane JC; Haymond S; Wang D; Wald EL
    Pediatr Crit Care Med; 2012 Jul; 13(4):435-40. PubMed ID: 22596066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystatin C or creatinine for detection of stage 3 chronic kidney disease in anorexia nervosa.
    Delanaye P; Cavalier E; Radermecker RP; Paquot N; Depas G; Chapelle JP; Scheen AJ; Krzesinski JM
    Nephron Clin Pract; 2008; 110(3):c158-63. PubMed ID: 18953178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cystatin C in elderly cardiac surgery patients.
    Ristikankare A; Pöyhiä R; Kuitunen A; Skrifvars M; Hämmäinen P; Salmenperä M; Suojaranta-Ylinen R
    Ann Thorac Surg; 2010 Mar; 89(3):689-94. PubMed ID: 20172110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepancies between creatinine-based and cystatin C-based equations in estimating prevalence of stage 3 chronic kidney disease in an elderly population.
    Delanaye P; Cavalier E; Saint-Remy A; Lutteri L; Krzesinski JM
    Scand J Clin Lab Invest; 2009; 69(3):344-9. PubMed ID: 19051098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.